Andrew Spaventa insider trades: Singular Genomics Systems (OMIC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | OMIC | ↓ Sell | 800 | $19.89 | $16K | Direct | Feb 14, 2025 (0d) |
| Dec 16, 2024 | OMIC | ↓ Sell | 180 | $20.16 | $4K | Direct | Dec 17, 2024 (1d) |
| Nov 12, 2024 | OMIC | ↓ Sell | 695 | $22.55 | $16K | Direct | Nov 13, 2024 (1d) |
| Sep 15, 2024 | OMIC | ↓ Sell | 175 | $12.38 | $2K | Direct | Sep 17, 2024 (2d) |
| Nov 17, 2023 | OMIC | ↑ Buy | 118,468 | $0.42 | $50K | By The Andrew K. Spaventa Living Trust d | Nov 20, 2023 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Andrew Spaventa's insider trades
Andrew Spaventa is Chief Executive Officer at Singular Genomics Systems (OMIC). Since Nov 17, 2023, Andrew has reported 1 open-market purchase worth $50K and 4 sales worth $37K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include gifts (11 filings), option exercises (11 filings), grants and awards (3 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OMIC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.